glucuronic acid has been researched along with Alloxan Diabetes in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (6.45) | 18.7374 |
1990's | 23 (24.73) | 18.2507 |
2000's | 19 (20.43) | 29.6817 |
2010's | 45 (48.39) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chakraborti, AS; Kundu, PP; Maity, S; Mukhopadhyay, P | 1 |
Antonioli, B; Chlapanidas, T; Crivelli, B; Galuzzi, M; Grillo, F; Marazzi, M; Mastracci, L; Perteghella, S; Preda, S; Torre, ML; Tosca, MC; Tripodo, G; Vigani, B | 1 |
Jiang, G; Liu, D; Xu, B; Yu, W; Zhang, Y; Zhou, J | 1 |
Buhler, LH; Gerber-Lemaire, S; Gonelle-Gispert, C; Mahou, R; Meier, RPH; Montanari, E; Seebach, JD; Wandrey, C | 1 |
Chakraborti, AS; Kundu, PP; Maity, S; Mandal, S; Mukhopadhyay, P; Prajapati, AK | 1 |
An, D; Chiu, A; Christophersen, NS; Fan, J; Fels, JJ; Flanders, JA; Grunnet, LG; Ingvorsen, C; Ji, Y; Lu, YC; Luo, D; Ma, M; Pardo, Y; Qi, L; Sand, FW; Shou, D; Silberstein, M; Song, W; Winkel, L | 1 |
Nayak, AK; Pal, D | 2 |
Aguirre, JJ; Gainza, G; Hernández, RM; Igartua, M; Pedraz, JL | 1 |
Alexander, M; Arora, RP; Choi, B; Foster, CE; Krishnan, R; Lakey, JR; Lamb, MW; White, SM | 1 |
Di, J; Gu, X; Gu, Z; Jiang, X; Jing, Y; Price, J | 1 |
Mazumder, B; Sharma, VK | 1 |
Bowden, S; Brey, EM; Farney, AC; Jenkins, R; McQuilling, JP; Opara, EC; Orlando, G; Pareta, R; Sittadjody, S | 1 |
Devarajan, PV; Patil, NH | 1 |
Al-Salami, H; Al-Sallami, HS; Arfuso, F; Chen-Tan, N; Fakhoury, M; Fang, Z; Golocorbin-Kon, S; Mikov, M; Mooranian, A; Mukkur, T; Negrulj, R | 1 |
Bhattacharya, S; Chakraborty, S; Kundu, PP; Mishra, R; Mukhopadhyay, P | 1 |
Al-Salami, H; Al-Sallami, HS; Arfuso, F; Aruso, F; Fakhoury, M; Fang, Z; Golocorbin-Kon, S; Mikov, M; Mooranian, A; Negrulj, R | 1 |
Auster, ME; Leal, EC; Min, J; Mooney, DJ; Pradhan-Nabzdyk, L; Shih, W; Silva, EA; Tellechea, A; Veves, A | 1 |
Ham, DS; Hong, TH; Khang, G; Kim, JW; Lee, SH; Park, CG; Park, HS; Sun, CL; Yang, HK; Yoon, KH | 1 |
Gu, Q; Liu, F; Mei, J; Pan, Y; Shao, M; Wang, T; Wu, H; Zhang, J; Zhang, Z; Zhao, J | 1 |
Gianello, P | 1 |
Abrahim-Vieira, B; Cabral, LM; Fonte, P; Lira, T; Lopes, MA; Oliveira, C; Ribeiro, AJ; Rodrigues, CR; Sarmento, B; Seiça, R; Sequeira, JA; Souza, AM; Veiga, F | 1 |
Cho, JH; Ham, DS; Hong, TH; Khang, G; Kim, JW; Kim, MJ; Kim, OY; Lee, SH; Park, HS; Rhee, M; Shin, J; Yang, HK; Yoon, KH; You, YH | 1 |
Al-Salami, H; Arfuso, F; Chen-Tan, N; Mathavan, S | 1 |
Chen, Z; Cheng, D; Dong, L; Gao, Y; Han, Y; Xu, H; Yao, J; Yi, T; Yin, N | 1 |
Dwivedi, P; Gupta, GK; Gupta, PK; Mishra, PR; Sharma, S; Singh, A; Teja, BV; Trivedi, R; Verma, A | 1 |
Ideta, T; Kochi, T; Kubota, M; Miyazaki, T; Moriwaki, H; Sakai, H; Shimizu, M; Shirakami, Y; Tanaka, T | 1 |
de Haan, BJ; de Vos, P; Llacua, A; Smink, SA | 1 |
Baker, AB; Das, S; Dunn, AK; Lam, B; Martin, PE; Monteforte, AJ; Mukhopadhyay, S; Wright, CS | 1 |
David, A; Day, J; Shikanov, A | 1 |
Abdel-Mohsen, AM; Hebeish, A; Jancar, J; Montaser, AS; Ramadan, MA; Sahffie, NM; Sleem, AA | 1 |
Fu, SH; Hsu, BR | 1 |
Enck, K; McQuilling, JP; Opara, EC; Orlando, G; Sivanandane, S; Tamburrini, R | 1 |
Bhanjana, G; Dhingra, D; Dilbaghi, N; Kim, KH; Kumar, S; Verma, RK | 1 |
Kasacka, I; Lewandowska, A; Sosnowska, K; Szekalska, M; Winnicka, K; Zakrzeska, A | 1 |
Adikwu, MU; Attama, AA; Builders, MI; Builders, PF; Kunle, OO; Okpaku, LC | 1 |
Liu, C; Lu, Y; Miao, X; Wu, X; Xu, K | 1 |
Chen, JB; Chen, X; Matthias, C; Qi, ZQ; Shan, SG; Shao, W; Zhang, L | 1 |
Lv, P; Ma, G; Wang, L; Wei, W; Zhang, Y | 1 |
Klein, HH; Schneider, S | 1 |
Barbaro, B; Oberholzer, J; Tuch, BE; Vaithilingam, V | 1 |
Dufrane, D; Gianello, P; Goebbels, RM | 1 |
Cormode, DP; Fayad, ZA; Mulder, WJ | 1 |
Gao, Y; Li, G; Lim, SK; Shao, S; Xie, B; Xie, F | 1 |
Arepally, A; Arifin, DR; Bulte, JW; Gilad, AA; Hyeon, T; Kim, H; Kim, J; Kim, T; Muja, N | 1 |
Anderson, DG; Bratlie, KM; Chen, D; Chiu, A; Cohen, J; Dang, T; Dholakia, N; Doloff, JC; Hollister-Lock, J; Ma, M; Sahay, G; Thakrar, R; Vegas, A; Weir, GC; York, RL | 1 |
Hu, S; Li, X; Lu, Y; Qi, J; Wu, W; Xie, Y; Xu, Y; Zhang, X | 1 |
Hasnain, SM; Nayak, AK; Pal, D | 1 |
Bonner-Weir, S; Duvivier-Kali, VF; Omer, A; Trivedi, N; Weir, GC; Wilmot, K | 1 |
Al-Jazaeri, A; Wright, JR; Yang, H | 1 |
SHAW, WN; WINEGRAD, AI | 1 |
Andersson, A; King, A; Lau, J; Nordin, A; Sandler, S | 1 |
Feilen, PJ; Kann, P; Kraus, O; Schneider, S; von Mach, MA | 1 |
Ijima, H; Kawakami, K; Ono, T; Sakai, S | 1 |
Basta, G; Becchetti, E; Brunetti, P; Calafiore, R; Calvitti, M; Capitani, S; Luca, G; Nastruzzi, C; Neri, L; Ricci, M; Rossi, C | 1 |
Basta, G; Brunetti, P; Calabrese, G; Calafiore, R; Calvitti, M; Guido, L; Luca, G; Macchiarulo, G; Mancuso, F; Racanicchi, L | 1 |
Choi, YS; Lee, KS; Seo, JS | 1 |
Bambra, C; Basta, P; Calafiore, R; Elliott, RB; Emerich, DF; Escobar, L; Garkavenko, O; Tan, PL; Thanos, C; Vasconcellos, AV | 1 |
Figueiredo, IV; Gonçalves, AR; Ribeiro, AJ; Silva, CM; Veiga, F | 1 |
Adobati, F; Cornolti, R; Fagiani, A; Figliuzzi, M; Plati, T; Remuzzi, A; Remuzzi, G; Rossi, L | 1 |
Houng, S; Neufeld, RJ; Reis, CP; Ribeiro, AJ; Veiga, F | 1 |
Al-Faadhel, MM; Al-Gohary, OM; Al-Kassas, RS | 1 |
Foster, JL; Tuch, BE; Williams, G; Williams, LJ | 1 |
Ferreira, D; Neufeld, R; Ribeiro, A; Sampaio, P; Sarmento, B; Veiga, F | 1 |
Krylov, IuF; Neugodova, NP; Smirnov, PA | 1 |
Brotzu, G; Cappai, A; Congiu, T; De Seta, W; Dessy, E; Petruzzo, P; Ruiu, G; Santa Cruz, G | 1 |
Chick, WL; Ecker, D; Kühtreiber, WM; Lanza, RP; Staruk, JE | 1 |
Chick, WL; Ecker, D; Kühtreiber, WM; Lanza, RP; Marsh, J; Staruk, JE | 1 |
Brotzu, G; Cappai, A; Petruzzo, P; Ruiu, G | 1 |
Chang, TM; Chen, CF; Chern, HT; Leu, FJ; Shian, LR; Sun, AM | 1 |
He, J; Shu, C | 1 |
Cochrum, K; Dorian, R; Jemtrud, S | 1 |
Chick, WL; Ecker, DM; Kühtreiber, WM; Lanza, RP; Marsh, JP | 2 |
Ao, Z; Colby, CB; Flashner, M; Korbutt, GS; Luskey, KL; Rajotte, RV; Warnock, GL | 1 |
Ao, Z; Colby, CB; Flashner, M; Korbutt, GS; Lakey, JR; Rajotte, RV; Warnock, GL | 1 |
Basta, G; Brunetti, P; Calafiore, R; Luca, G; Osticioli, L; Tortoioli, C | 1 |
Chick, WL; Ecker, DM; Kühtreiber, WM; Lanza, RP; Marsh, JP; Staruk, JE | 1 |
Wang, TG | 1 |
Orłowski, T; Sabat, M; Sitarek, E; Tatarkiewicz, K | 1 |
Fiedor, P; Orłowski, T; Sabat, M; Samsel, R; Sitarek, E; Tatarkiewicz, K | 1 |
Gamian, E; Kochman, A; Rabczyński, J | 1 |
Duvivier-Kali, VF; O'Neil, JJ; Omer, A; Parent, RJ; Weir, GC | 1 |
Dionne, K; Gentile, F; Gerasimidi-Vazeou, A; Hazlett, T; Hegre, O; Lacy, PE; Lysaght, M | 1 |
Borland, KM; Butler, DH; Faustman, DL; Harvey, JM; Lanza, RP; Maki, T; Monaco, AP; Muller, TE; Rupp, RG; Solomon, BA | 1 |
Bell, PR; Clayton, HA; Colloby, PS; James, RF; London, NJ | 1 |
Ahrén, B; Ar'Rajab, A; Bengmark, S | 1 |
Fan, MY; Fu, XW; Levesque, L; Lum, ZP; Sun, AM; Tai, IT | 1 |
Emudianughe, TS | 1 |
O'Shea, GM; Sun, AM | 1 |
Alejandro, R; Calafiore, R; Mintz, DH; Needell, SD; Tsang, WG | 1 |
Alejandro, R; Calafiore, R; Civantos, F; Koh, N; Needell, SD; Shienvold, FL | 1 |
Coletta, AV; David, R; Jarrell, BE; Karam, J | 1 |
3 review(s) available for glucuronic acid and Alloxan Diabetes
Article | Year |
---|---|
Macroencapsulated Pig Islets Correct Induced Diabetes in Primates up to 6 Months.
Topics: Alginates; Animals; Biocompatible Materials; Blood Glucose; Diabetes Mellitus, Experimental; Glucuronic Acid; Graft Survival; Hexuronic Acids; Immunocompetence; Islets of Langerhans; Islets of Langerhans Transplantation; Macaca fascicularis; Membranes, Artificial; Permeability; Skin; Swine; Transplantation, Heterologous | 2015 |
Immunoisolation to prevent tissue graft rejection: Current knowledge and future use.
Topics: Alginates; Animals; Diabetes Mellitus, Experimental; Glucuronic Acid; Graft Rejection; Hexuronic Acids; Humans; Hydrogels; Mice; Transplantation, Homologous | 2016 |
[Role of drug biotransformation in the realization of the pharmacological effect].
Topics: Acetylation; Aging; Amines; Animals; Biotransformation; Diabetes Mellitus; Diabetes Mellitus, Experimental; Glucuronates; Glucuronic Acid; Hormones; Humans; Hydrolysis; Kinetics; Liver; Male; Rats; Structure-Activity Relationship; Vitamins | 1984 |
90 other study(ies) available for glucuronic acid and Alloxan Diabetes
Article | Year |
---|---|
Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals-An in vitro and in vivo approach.
Topics: Administration, Oral; Alginates; Animals; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Flavanones; Glucuronic Acid; Hexuronic Acids; Nanoparticles; Particle Size; Rats | 2017 |
Stromal Vascular Fraction Loaded Silk Fibroin Mats Effectively Support the Survival of Diabetic Mice after Pancreatic Islet Transplantation.
Topics: Alginates; Animals; Cell Survival; Diabetes Mellitus, Experimental; Fibroins; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans Transplantation; Male; Mice | 2017 |
Polymer microneedles fabricated from alginate and hyaluronate for transdermal delivery of insulin.
Topics: Administration, Cutaneous; Alginates; Animals; Diabetes Mellitus, Experimental; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Mice; Needles; Polymers | 2017 |
Multipotent mesenchymal stromal cells enhance insulin secretion from human islets via N-cadherin interaction and prolong function of transplanted encapsulated islets in mice.
Topics: Alginates; Animals; Blood Glucose; Cadherins; Cells, Cultured; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Microspheres; Pluripotent Stem Cells; Polyethylene Glycols | 2017 |
Preparation, characterization and in vivo evaluation of pH sensitive, safe quercetin-succinylated chitosan-alginate core-shell-corona nanoparticle for diabetes treatment.
Topics: Administration, Oral; Alginates; Animals; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; HT29 Cells; Humans; Hydrogen-Ion Concentration; Hypoglycemic Agents; Male; Nanoparticles; Particle Size; Quercetin; Rats; Rats, Wistar; Succinic Acid | 2018 |
Designing a retrievable and scalable cell encapsulation device for potential treatment of type 1 diabetes.
Topics: Alginates; Animals; Cell- and Tissue-Based Therapy; Diabetes Mellitus, Experimental; Dimethylformamide; Dogs; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogels; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mice, SCID; Polymethyl Methacrylate; Rats | 2018 |
Formulation optimization and evaluation of jackfruit seed starch-alginate mucoadhesive beads of metformin HCl.
Topics: Alginates; Alloxan; Animals; Artocarpus; Calcium Chloride; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Drug Compounding; Factor Analysis, Statistical; Gels; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypoglycemic Agents; Kinetics; Male; Metformin; Rats; Seeds; Starch; Water | 2013 |
rhEGF-loaded PLGA-Alginate microspheres enhance the healing of full-thickness excisional wounds in diabetised Wistar rats.
Topics: 3T3 Cells; Alginates; Animals; Cell Movement; Cell Proliferation; Diabetes Mellitus, Experimental; Epidermal Growth Factor; Glucuronic Acid; Hexuronic Acids; Humans; Lactic Acid; Male; Mice; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Recombinant Proteins; Wound Healing | 2013 |
Noninvasive evaluation of the vascular response to transplantation of alginate encapsulated islets using the dorsal skin-fold model.
Topics: Alginates; Animals; Bioprosthesis; Cells, Immobilized; Diabetes Mellitus, Experimental; Equipment Design; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Neovascularization, Physiologic; Swine | 2014 |
Ultrasound-triggered regulation of blood glucose levels using injectable nano-network.
Topics: Alginates; Animals; Blood Glucose; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Insulin; Lactic Acid; Male; Mice; Mice, Inbred C57BL; Nanostructures; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Ultrasonic Therapy | 2014 |
Gastrointestinal transition and anti-diabetic effect of Isabgol husk microparticles containing gliclazide.
Topics: Alginates; Animals; Blood Glucose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Drug Carriers; Gliclazide; Glucose; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Intestine, Small; Microspheres; Particle Size; Psyllium; Rabbits; Solubility; Tablets | 2014 |
Long-term function of islets encapsulated in a redesigned alginate microcapsule construct in omentum pouches of immune-competent diabetic rats.
Topics: Alginates; Angiogenesis Inducing Agents; Animals; Blood Glucose; Cell Survival; Diabetes Mellitus, Experimental; Fibroblast Growth Factor 1; Glucuronic Acid; Graft Survival; Hexuronic Acids; Immunocompetence; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Neovascularization, Physiologic; Omentum; Rats, Inbred Lew; Rats, Wistar; Time Factors; Tissue Scaffolds | 2014 |
Insulin-loaded alginic acid nanoparticles for sublingual delivery.
Topics: Adhesiveness; Administration, Sublingual; Alginates; Animals; Biomarkers; Blood Glucose; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Circular Dichroism; Diabetes Mellitus, Experimental; Drug Carriers; Drug Compounding; Drug Stability; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Male; Mouth Mucosa; Nanoparticles; Nanotechnology; Niacinamide; Oral Mucosal Absorption; Particle Size; Permeability; Rats, Wistar; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical | 2016 |
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study.
Topics: Alginates; Animals; Artificial Cells; Capsules; Chemistry, Pharmaceutical; Deoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Particle Size; Rats; Rheology | 2014 |
pH-sensitive chitosan/alginate core-shell nanoparticles for efficient and safe oral insulin delivery.
Topics: Administration, Oral; Alginates; Animals; Biological Availability; Chitosan; Diabetes Mellitus, Experimental; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Insulin; Nanoparticles | 2015 |
Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment.
Topics: Alginates; Animals; Capsules; Deoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Delivery Systems; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Rats | 2015 |
Alginate and DNA Gels Are Suitable Delivery Systems for Diabetic Wound Healing.
Topics: Alginates; Animals; Bandages; Biocompatible Materials; Diabetes Mellitus, Experimental; Diabetic Foot; Drug Carriers; Drug Delivery Systems; Gels; Glucuronic Acid; Hexuronic Acids; Mice; Mice, Inbred C57BL; Vascular Endothelial Growth Factor A; Wound Healing | 2015 |
Antifibrotic effect of rapamycin containing polyethylene glycol-coated alginate microcapsule in islet xenotransplantation.
Topics: Alginates; Animals; Biocompatible Materials; Blood Glucose; Capsules; Cell Proliferation; Cell Survival; Coated Materials, Biocompatible; Diabetes Mellitus, Experimental; Fibrosis; Glucose; Glucuronic Acid; Hexuronic Acids; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Mice, Inbred BALB C; Polyethylene Glycols; RAW 264.7 Cells; Sirolimus; Sus scrofa; Transplantation, Heterologous | 2017 |
Calcium alginate enhances wound healing by up-regulating the ratio of collagen types I/III in diabetic rats.
Topics: Alginates; Animals; Collagen Type I; Collagen Type III; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucuronic Acid; Hexuronic Acids; Hydroxyproline; Male; Rats, Sprague-Dawley; Skin; Skin Ulcer; Time Factors; Wound Healing | 2015 |
Probing insulin bioactivity in oral nanoparticles produced by ultrasonication-assisted emulsification/internal gelation.
Topics: Alginates; Animals; Dextran Sulfate; Diabetes Mellitus, Experimental; Emulsions; Gels; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypoglycemic Agents; Insulin; Male; Nanoparticles; Rats; Rats, Wistar; Ultrasonics | 2015 |
Long-term Efficacy and Biocompatibility of Encapsulated Islet Transplantation With Chitosan-Coated Alginate Capsules in Mice and Canine Models of Diabetes.
Topics: Alginates; Animals; Barium Compounds; Blood Glucose; Cell Adhesion; Chitosan; Chlorides; Coated Materials, Biocompatible; Cross-Linking Reagents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dogs; Female; Fibrosis; Galactosyltransferases; Glucuronic Acid; Graft Survival; Heterografts; Hexuronic Acids; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Knockout; Porosity; RAW 264.7 Cells; Swine; Swine, Miniature; Time Factors; Transplantation, Homologous | 2016 |
A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes.
Topics: Alginates; Animals; Bile Acids and Salts; Blood Glucose; Capsules; Cell Survival; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug Compounding; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Particle Size; Solubility; Taurocholic Acid | 2016 |
VEGF-conjugated alginate hydrogel prompt angiogenesis and improve pancreatic islet engraftment and function in type 1 diabetes.
Topics: Alginates; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Hydrogel, Polyethylene Glycol Dimethacrylate; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Vascular Endothelial Growth Factor A | 2016 |
Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.
Topics: Administration, Oral; Alginates; Animals; Caco-2 Cells; Calcium Phosphates; Carbodiimides; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Electrolytes; Endocytosis; Flow Cytometry; Fluorescein-5-isothiocyanate; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Insulin; Male; Microscopy, Confocal; Microscopy, Fluorescence; Nanoparticles; Particle Size; Rats; Rats, Wistar; Vitamin B 12 | 2016 |
Sodium alginate prevents progression of non-alcoholic steatohepatitis and liver carcinogenesis in obese and diabetic mice.
Topics: Alginates; Animals; Cell Transformation, Neoplastic; Diabetes Mellitus, Experimental; Diethylnitrosamine; Glucuronic Acid; Hexuronic Acids; Hyperinsulinism; Inflammation; Insulin Resistance; Liver Neoplasms; Male; Mice; Mice, Inbred ICR; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress | 2016 |
Extracellular matrix components supporting human islet function in alginate-based immunoprotective microcapsules for treatment of diabetes.
Topics: Alginates; Animals; Capsules; Cell Survival; Collagen Type IV; Diabetes Mellitus, Experimental; Extracellular Matrix; Glucose; Glucuronic Acid; Hexuronic Acids; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Laminin; Oxygen Consumption; Peptides | 2016 |
Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis.
Topics: Alginates; Animals; Blood Vessels; Cell Movement; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Delivery Systems; Endosomes; Fibroblast Growth Factor 2; Glucuronic Acid; Glypicans; HEK293 Cells; HeLa Cells; Hexuronic Acids; Hindlimb; Human Umbilical Vein Endothelial Cells; Humans; Ischemia; Kinetics; Liposomes; Mice, Obese; Nanoparticles; Neovascularization, Physiologic; Proto-Oncogene Proteins c-akt; Signal Transduction; Skin; Vascular Endothelial Growth Factor A | 2016 |
Preparation and characterization of alginate/silver/nicotinamide nanocomposites for treating diabetic wounds.
Topics: Administration, Cutaneous; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bandages; Burns; Diabetes Mellitus, Experimental; Escherichia coli; Escherichia coli Infections; Glucuronic Acid; Hexuronic Acids; Metal Nanoparticles; Nanocomposites; Niacinamide; Particle Size; Rabbits; Rats; Silver; Skin; Staphylococcal Infections; Staphylococcus aureus; Streptozocin; Textiles | 2016 |
Field Effect Microparticle Generation for Cell Microencapsulation.
Topics: Alginates; Animals; Biocompatible Materials; Capsules; Cell Count; Cell Line; Cells, Immobilized; Diabetes Mellitus, Experimental; Drug Compounding; Electricity; Equipment Design; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice, Inbred BALB C; Particle Size; Polylysine; Rats; Rats, Sprague-Dawley | 2017 |
Selective Osmotic Shock (SOS)-Based Islet Isolation for Microencapsulation.
Topics: Alginates; Animals; Cell Separation; Cell Survival; Cells, Immobilized; Diabetes Mellitus, Experimental; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Osmotic Pressure; Rats | 2017 |
Metformin-loaded alginate nanoparticles as an effective antidiabetic agent for controlled drug release.
Topics: Alginates; Animals; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Drug Carriers; Drug Liberation; Emulsions; Female; Glucose Tolerance Test; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Male; Metformin; Nanocapsules; Nanoparticles; Particle Size; Rats | 2017 |
The Influence of Chitosan Cross-linking on the Properties of Alginate Microparticles with Metformin Hydrochloride-In Vitro and In Vivo Evaluation.
Topics: Alginates; Animals; Blood Glucose; Chemistry, Pharmaceutical; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Drug Carriers; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Kidney; Liver; Male; Metformin; Pancreas; Particle Size; Rats; Rats, Wistar; Streptozocin | 2017 |
Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
Topics: Administration, Oral; Alginates; Animals; Blood Glucose; Capsules; Chemistry, Pharmaceutical; Diabetes Mellitus, Experimental; Drug Carriers; Drug Compounding; Gelatin; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Mucins; Particle Size; Rabbits; Solubility; Surface Properties; Technology, Pharmaceutical | 2008 |
Increased expression of myo-inositol oxygenase is involved in the tubulointerstitial injury of diabetic nephropathy.
Topics: Actins; Animals; Cadherins; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Gene Expression Regulation, Enzymologic; Glucose; Glucuronic Acid; Inositol; Inositol Oxygenase; Kidney Tubules; Male; Mice; Mice, Inbred NOD; Rats; RNA, Messenger; Sweetening Agents | 2009 |
Allotransplantation of sulphate glucomannan-alginate barium (SGA)-microencapsulated rat islets for the treatment of diabetes mellitus.
Topics: Alginates; Animals; Barium Sulfate; Blood Glucose; Chemokine CCL2; Diabetes Mellitus, Experimental; Enzyme-Linked Immunosorbent Assay; Glucuronic Acid; Hexuronic Acids; Interferon-gamma; Interleukin-1; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mannans; Microspheres; Polylysine; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley; Transplantation, Homologous; Treatment Outcome; Tumor Necrosis Factor-alpha | 2009 |
Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Topics: Administration, Oral; Alginates; Animals; Blood Glucose; Chitosan; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Drug Carriers; Drug Stability; Gastric Juice; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypoglycemic Agents; Insulin; Male; Microspheres; Particle Size; Rats; Rats, Sprague-Dawley; Solubility; Surface Properties; Tissue Distribution | 2011 |
Preserved insulin secretion capacity and graft function of cryostored encapsulated rat islets.
Topics: Alginates; Animals; Bioartificial Organs; Cryopreservation; Cryoprotective Agents; Diabetes Mellitus, Experimental; Dimethyl Sulfoxide; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Rats; Rats, Wistar | 2011 |
Functional capacity of human islets after long-distance shipment and encapsulation.
Topics: Adult; Alginates; Animals; Blood Glucose; Cell Survival; Cells, Cultured; Chicago; Diabetes Mellitus, Experimental; Female; Glucose Tolerance Test; Glucuronic Acid; Hexuronic Acids; Humans; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mice, Inbred NOD; Mice, SCID; New South Wales; Time Factors; Tissue and Organ Harvesting; Transportation | 2011 |
Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression.
Topics: Alginates; Animals; Antibodies, Heterophile; Blood Glucose; C-Peptide; Capsules; Diabetes Mellitus, Experimental; Glucuronic Acid; Glycated Hemoglobin; Graft Survival; Hexuronic Acids; Immunosuppression Therapy; Insulin; Islets of Langerhans Transplantation; Macaca fascicularis; Subcutaneous Tissue; Sus scrofa; Time Factors; Transplantation, Heterologous | 2010 |
Science to practice: versatile method to track transplanted encapsulated islet cells with multiple imaging modalities.
Topics: Alginates; Animals; Capsules; Diabetes Mellitus, Experimental; Diagnostic Imaging; Fluorocarbons; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans Transplantation; Magnetic Resonance Imaging; Mice; Tomography, X-Ray Computed; Ultrasonography | 2011 |
Correction of hyperglycemia in type 1 diabetic models by transplantation of encapsulated insulin-producing cells derived from mouse embryo progenitor.
Topics: Alginates; Animals; Capsules; Cell Differentiation; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Embryonic Stem Cells; Glucose Tolerance Test; Glucuronic Acid; Hexuronic Acids; Hyperglycemia; Insulin; Insulin Secretion; Insulin-Secreting Cells; Male; Mice; Mice, Inbred BALB C; Treatment Outcome | 2011 |
Multifunctional capsule-in-capsules for immunoprotection and trimodal imaging.
Topics: Alginates; Animals; Capsules; Cell Line, Tumor; Diabetes Mellitus, Experimental; Female; Glucuronic Acid; Hexuronic Acids; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Nanoparticles; Ultrasonography | 2011 |
Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate-methyl cellulose mucoadhesive microcapsules.
Topics: Adhesiveness; Administration, Oral; Alginates; Animals; Blood Glucose; Calcium Chloride; Capsules; Chemistry, Pharmaceutical; Cross-Linking Reagents; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Drug Carriers; Drug Compounding; Female; Gliclazide; Glucuronic Acid; Goats; Hexuronic Acids; Hypoglycemic Agents; Intestinal Mucosa; Male; Methylcellulose; Models, Statistical; Particle Size; Rats; Solubility; Technology, Pharmaceutical; Time Factors | 2011 |
Core-shell hydrogel microcapsules for improved islets encapsulation.
Topics: Alginates; Animals; Biocompatible Materials; Capsules; Cell Culture Techniques; Cells, Cultured; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Hydrogels; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred C57BL; Porosity; Streptozocin; Tissue Scaffolds; Treatment Outcome | 2013 |
Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats.
Topics: Administration, Oral; Alginates; Analysis of Variance; Animals; Blood Glucose; Chitosan; Circular Dichroism; Diabetes Mellitus, Experimental; Drug Carriers; Drug Stability; Emulsions; Gastric Juice; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Insulin; Male; Models, Biological; Nanoparticles; Particle Size; Rats; Rats, Wistar | 2013 |
Development, optimization and in vitro-in vivo evaluation of pioglitazone- loaded jackfruit seed starch-alginate beads.
Topics: Alginates; Animals; Artocarpus; Blood Glucose; Calcium Chloride; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Female; Fruit; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Male; Microscopy, Electron, Scanning; Particle Size; Pioglitazone; Rats; Seeds; Spectroscopy, Fourier Transform Infrared; Starch; Thiazolidinediones | 2013 |
Survival and maturation of microencapsulated porcine neonatal pancreatic cell clusters transplanted into immunocompetent diabetic mice.
Topics: Alginates; Animals; Animals, Newborn; Blood Glucose; Capsules; Cell Differentiation; Cell Division; Cell Survival; Cellular Senescence; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Glucuronic Acid; Hexuronic Acids; Immunocompetence; Immunoglobulin G; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred Strains; Swine; Time Factors; Transplantation, Heterologous | 2003 |
The immunoprotective effect of Sertoli cells coencapsulated with islet xenografts is not dependent upon Fas ligand expression.
Topics: Alginates; Animals; Diabetes Mellitus, Experimental; Fas Ligand Protein; Glucuronic Acid; Graft Survival; Hexuronic Acids; Islets of Langerhans Transplantation; Male; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Sertoli Cells; Transplantation, Heterologous | 2002 |
GLUCURONIC ACID PATHWAY ACTIVITY IN ADIPOSE TISSUE.
Topics: Adipose Tissue; Animals; Barbiturates; Carbohydrate Metabolism; Carbon Isotopes; Diabetes Mellitus, Experimental; Glucose; Glucuronates; Glucuronic Acid; Growth Hormone; Lactones; Pharmacology; Rats; Research; Sodium Chloride; Starvation | 1964 |
The effect of capsule composition in the reversal of hyperglycemia in diabetic mice transplanted with microencapsulated allogeneic islets.
Topics: Alginates; Animals; Blood Glucose; Capsules; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucuronic Acid; Hexuronic Acids; Hyperglycemia; Islets of Langerhans Transplantation; Mice; Mice, Inbred C57BL; Mice, Nude; Polylysine; Skin Transplantation; Transplantation, Homologous | 2003 |
Intraportal transplantation of allogenic pancreatic islets encapsulated in barium alginate beads in diabetic rats.
Topics: Alginates; Animals; Blood Glucose; Cell Death; Diabetes Mellitus, Experimental; Drug Carriers; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Liver; Portal System; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley | 2003 |
MIN6 cells-enclosing aminopropyl-silicate membrane templated by alginate gels differences in guluronic acid content.
Topics: Alginates; Animals; Capsules; Cell Line, Tumor; Cell Survival; Cell Transplantation; Diabetes Mellitus, Experimental; Gels; Glucuronic Acid; Insulinoma; Male; Mice; Mice, Inbred Strains; Silicates | 2004 |
Improved function of rat islets upon co-microencapsulation with Sertoli's cells in alginate/poly-L-ornithine.
Topics: Alginates; Animals; Cells, Cultured; Coculture Techniques; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mitosis; Peptides; Rats; Sertoli Cells | 2001 |
Grafts of microencapsulated pancreatic islet cells for the therapy of diabetes mellitus in non-immunosuppressed animals.
Topics: Alginates; Animals; Animals, Newborn; Cell Culture Techniques; Cell Size; Cell Survival; Cells, Cultured; Diabetes Mellitus, Experimental; Dogs; Glucuronic Acid; Graft Rejection; Hexuronic Acids; Immunocompromised Host; Islets of Langerhans; Islets of Langerhans Transplantation; Membranes, Artificial; Mice; Streptozocin; Swine; Treatment Outcome | 2004 |
Sea tangle supplementation lowers blood glucose and supports antioxidant systems in streptozotocin-induced diabetic rats.
Topics: Alginates; alpha-Tocopherol; Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diet; Dietary Supplements; Diterpenes; Eating; Glucuronic Acid; Hexuronic Acids; Liver; Male; Phaeophyceae; Rats; Rats, Sprague-Dawley; Retinyl Esters; Vitamin A | 2004 |
Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates.
Topics: Alginates; Animals; Animals, Newborn; Blood Glucose; Capsules; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucuronic Acid; Hexuronic Acids; Insulin; Islets of Langerhans Transplantation; Macaca fascicularis; Male; Swine; Transplantation, Heterologous | 2005 |
Alginate microspheres prepared by internal gelation: development and effect on insulin stability.
Topics: Alginates; Animals; Blood Glucose; Chemistry, Pharmaceutical; Diabetes Mellitus, Experimental; Drug Stability; Emulsions; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Male; Microspheres; Particle Size; Protein Denaturation; Rats; Rats, Wistar; Recombinant Proteins; Solubility; Streptozocin; Technology, Pharmaceutical | 2006 |
Biocompatibility and function of microencapsulated pancreatic islets.
Topics: Alginates; Animals; Biocompatible Materials; Blood Glucose; Capsules; Cattle; Cell Separation; Centrifugation, Density Gradient; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Rats; Rats, Wistar; Transplantation, Heterologous; Ultracentrifugation | 2006 |
Nanoparticulate delivery system for insulin: design, characterization and in vitro/in vivo bioactivity.
Topics: Alginates; Animals; Blood Glucose; Blotting, Western; Cells, Cultured; Chemistry, Pharmaceutical; Dextran Sulfate; Diabetes Mellitus, Experimental; Drug Carriers; Drug Compounding; Drug Stability; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypoglycemic Agents; Injections, Subcutaneous; Insulin; Lasers; Male; Microscopy, Electron, Transmission; Myoblasts; Nanoparticles; Particle Size; Rats; Rats, Wistar; Scattering, Radiation; Solubility; Technology, Pharmaceutical; Time Factors | 2007 |
Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
Topics: Administration, Oral; Alginates; Animals; Blood Glucose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Carriers; Drug Compounding; Gels; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypoglycemic Agents; Intestinal Absorption; Male; Microspheres; Particle Size; Rabbits; Solubility; Surface-Active Agents; Tablets; Technology, Pharmaceutical | 2007 |
Differentiation of transplanted microencapsulated fetal pancreatic cells.
Topics: Alginates; Animals; Blood Glucose; Capsules; Cell Aggregation; Cell Differentiation; Cell Survival; Diabetes Mellitus, Experimental; Fetal Tissue Transplantation; Fluorescent Antibody Technique; Glucagon; Glucose; Glucuronic Acid; Hexuronic Acids; Insulin; Insulin Secretion; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Mice, SCID; Pancreas; Staining and Labeling; Time Factors | 2007 |
Alginate/chitosan nanoparticles are effective for oral insulin delivery.
Topics: Administration, Oral; Alginates; Animals; Biological Availability; Blood Glucose; Chemistry, Pharmaceutical; Chitosan; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Fluorescein-5-isothiocyanate; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypoglycemic Agents; Insulin; Intestinal Absorption; Intestinal Mucosa; Male; Microscopy, Confocal; Nanoparticles; Particle Size; Rats; Rats, Wistar; Solubility | 2007 |
Evaluation of new small barium alginate microcapsules.
Topics: Alginates; Animals; Biocompatible Materials; Capsules; Cell Survival; Cell Transplantation; Diabetes Mellitus, Experimental; Drug Carriers; Erythrocytes; Glucuronic Acid; Hexuronic Acids; Humans; Hyperglycemia; Insulin; Islets of Langerhans; Microscopy, Electron; Microscopy, Electron, Scanning; Microspheres; Oxygen; Rats; Rats, Wistar; Swine; Uronic Acids | 1995 |
Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres.
Topics: Alginates; Animals; Cattle; Diabetes Mellitus, Experimental; Glucose; Glucuronic Acid; Hexuronic Acids; Immunoglobulin G; Insulin; Islets of Langerhans Transplantation; Kinetics; Male; Mice; Mice, Inbred C57BL; Microspheres; Peritoneal Cavity; Swine; Thyroglobulin; Transplantation, Heterologous | 1995 |
A simple method for transplanting discordant islets into rats using alginate gel spheres.
Topics: Alginates; Animals; Cattle; Diabetes Mellitus, Experimental; Gels; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans Transplantation; Male; Microspheres; Peritoneal Cavity; Prostheses and Implants; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 1995 |
Cell microencapsulation: a new method.
Topics: Alginates; Animals; Blood Glucose; Capsules; Cell Transplantation; Diabetes Mellitus, Experimental; Erythrocyte Transfusion; Erythrocytes; Glucuronic Acid; Hexuronic Acids; Humans; Islets of Langerhans; Islets of Langerhans Transplantation; Microscopy, Electron; Rats; Swine; Transplantation, Heterologous | 1994 |
Xenotransplantation of microencapsulated canine islets into diabetic rats.
Topics: Alginates; Animals; Culture Techniques; Diabetes Mellitus, Experimental; Dogs; Drug Compounding; Glucuronic Acid; Hexuronic Acids; Insulin; Insulin Secretion; Islets of Langerhans Transplantation; Polylysine; Rats; Rats, Wistar; Transplantation, Heterologous | 1994 |
The long-term observation of the transplantation of encapsulated rat islets to the diabetic mice.
Topics: Alginates; Animals; Diabetes Mellitus, Experimental; Drug Compounding; Female; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans Transplantation; Mice; Polylysine; Rats; Rats, Sprague-Dawley | 1993 |
Successful xenografts in mice with microencapsulated rat and dog islets.
Topics: Alginates; Animals; Biocompatible Materials; Blood Glucose; Capsules; Diabetes Mellitus, Experimental; Dogs; Female; Glucuronic Acid; Graft Survival; Hexuronic Acids; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Mice; Mice, Inbred BALB C; Perfusion; Rats; Rats, Inbred F344; Transplantation, Heterologous; Transplantation, Homologous | 1995 |
Transplantation of porcine and bovine islets into mice without immunosuppression using uncoated alginate microspheres.
Topics: Alginates; Animals; Biocompatible Materials; Cattle; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Immunosuppression Therapy; Islets of Langerhans Transplantation; Mice; Mice, Inbred C57BL; Microspheres; Swine; Transplantation, Heterologous | 1995 |
A simple and inexpensive method for transplanting xenogeneic cells and tissues into rats using alginate gel spheres.
Topics: Alginates; Animals; Antibodies, Heterophile; Biocompatible Materials; Blood Glucose; Cattle; Diabetes Mellitus, Experimental; Gels; Glucuronic Acid; Graft Survival; Hexuronic Acids; Islets of Langerhans Transplantation; Microspheres; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 1995 |
Microencapsulation improves canine islet survival in vivo.
Topics: Alginates; Animals; Biocompatible Materials; Capsules; Cell Survival; Diabetes Mellitus, Experimental; Dogs; Glucuronic Acid; Graft Survival; Hexuronic Acids; Islets of Langerhans; Mice; Mice, Nude; Transplantation, Heterologous | 1995 |
Cryopreservation of microencapsulated canine islets.
Topics: Alginates; Animals; Biocompatible Materials; Capsules; Cryopreservation; Diabetes Mellitus, Experimental; Dogs; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Membranes, Artificial; Mice; Mice, Nude; Transplantation, Heterologous | 1995 |
Coherent microcapsules for pancreatic islet transplantation: a new approach for bioartificial pancreas.
Topics: Alginates; Animals; Capsules; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Humans; Insulin Infusion Systems; Islets of Langerhans Transplantation; Mice; Mice, Inbred Strains; Polyethylene Glycols; Rats; Rats, Inbred Lew; Rats, Inbred WF; Swine; Transplantation, Heterologous; Transplantation, Homologous | 1996 |
A simple method for xenotransplanting cells and tissues into rats using uncoated alginate microreactors.
Topics: Alginates; Animals; Antibodies, Heterophile; Biocompatible Materials; Blood Glucose; Cattle; Cyclosporine; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans Transplantation; Microspheres; Rats; Rats, Inbred Lew; Species Specificity; Swine; Transplantation, Heterologous | 1996 |
New technologies for bioartificial organs.
Topics: Alginates; Animals; Artificial Organs; Biomedical Engineering; Calcium Chloride; Cell Separation; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans Transplantation; Male; Membranes, Artificial; Mice; Models, Biological; Permeability; Polymers; Rats; Rats, Sprague-Dawley; Sodium Chloride; Tissue Donors | 1998 |
Reversal of hyperglycemia in streptozotocin diabetic mice by xenotransplantation of microencapsulated rat islets.
Topics: Alginates; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucuronic Acid; Heparin; Hexuronic Acids; Hyperglycemia; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred BALB C; Microspheres; Pancreas, Artificial; Polyethyleneimine; Polymers; Protamines; Rats; Transplantation, Heterologous | 1997 |
Experience with pancreas islets separation, immunoisolation and cryopreservation.
Topics: Alginates; Animals; Biocompatible Materials; Capsules; Cell Culture Techniques; Cell Separation; Cells, Cultured; Cryopreservation; Diabetes Mellitus, Experimental; Glucuronic Acid; Heparin; Hexuronic Acids; Humans; Indicators and Reagents; Insulin; Insulin Secretion; Islets of Langerhans; Mice; Polyethyleneimine; Polymers; Polypropylenes; Protamines; Rats; Sulfones; Swine; Time Factors; Transplantation, Heterologous | 1996 |
Evaluation of bioartificial pancreas function made from sodium alginate and poly-L-lisine microcapsules settled with viable pancreatic islets.
Topics: Alginates; Alloxan; Animals; Capsules; Diabetes Mellitus, Experimental; Female; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans; Liver; Male; Mice; Pancreas; Pancreas, Artificial; Polylysine; Rats; Rats, Inbred BUF | 1999 |
Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane.
Topics: Alginates; Animals; Autoimmunity; Biocompatible Materials; Blood Glucose; C-Peptide; Capsules; Coculture Techniques; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucose Tolerance Test; Glucuronic Acid; Graft Rejection; Graft Survival; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, Inbred Strains; Spleen; Subrenal Capsule Assay; T-Lymphocytes; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 2001 |
Reversal of streptozotocin diabetes in nonimmunosuppressed mice with immunoisolated xenogeneic rat islets.
Topics: Alginates; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucuronic Acid; Graft Rejection; Graft Survival; Hexuronic Acids; Immunity, Cellular; Islets of Langerhans Transplantation; Male; Membranes, Artificial; Mice; Mice, Inbred C57BL; Nephrectomy; Rats; Rats, Inbred WF; Transplantation, Heterologous | 1992 |
Successful xenotransplantation of a diffusion-based biohybrid artificial pancreas: a study using canine, bovine, and porcine islets.
Topics: Alginates; Analysis of Variance; Animals; Blood Glucose; Cattle; Cell Separation; Diabetes Mellitus, Experimental; Dogs; Glucuronic Acid; Hexuronic Acids; Insulin Infusion Systems; Islets of Langerhans; Islets of Langerhans Transplantation; Membranes, Artificial; Rats; Rats, Inbred Lew; Swine; Transplantation, Heterologous | 1992 |
The effect of capsule composition on the viability and biocompatibility of sodium alginate/poly-L-lysine encapsulated islets.
Topics: Alginates; Animals; Capsules; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucuronic Acid; Hexuronic Acids; Insulin Infusion Systems; Islets of Langerhans Transplantation; Polylysine; Rats; Rats, Inbred BB; Rats, Inbred Strains; Rats, Nude | 1992 |
Insulin secretion in streptozotocin-diabetic rats transplanted with immunoisolated islets.
Topics: Alginates; Animals; Blood Glucose; Cell Separation; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Kinetics; Male; Polylysine; Rats; Rats, Inbred Strains | 1991 |
Reversal of diabetes in BB rats by transplantation of encapsulated pancreatic islets.
Topics: Alginates; Animals; Body Weight; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Microscopy, Electron, Scanning; Rats; Rats, Inbred BB; Rats, Inbred Strains | 1990 |
Sex differences in salicylic acid metabolism in streptozotocin induced diabetes in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Female; Glucuronates; Glucuronic Acid; Hippurates; Male; Rats; Rats, Inbred Strains; Salicylates; Salicylic Acid; Sex Factors | 1990 |
Encapsulation of rat islets of Langerhans prolongs xenograft survival in diabetic mice.
Topics: Alginates; Animals; Diabetes Mellitus, Experimental; Glucuronic Acid; Hexuronic Acids; Islets of Langerhans Transplantation; Membranes, Artificial; Mice; Mice, Inbred BALB C; Peptides; Polylysine; Rats; Rats, Inbred Strains; Transplantation, Heterologous | 1986 |
[Microencapsulation of living cells and tissues. Theoretical and practical aspects].
Topics: Alginates; Animals; Biocompatible Materials; Capsules; Cells, Cultured; Diabetes Mellitus, Experimental; Dogs; Glucuronic Acid; Graft Rejection; Hexuronic Acids; Humans; In Vitro Techniques; Islets of Langerhans Transplantation; Mice; Microspheres; Rats; Transplantation, Heterologous | 1987 |
Xenotransplantation of microencapsulated canine islets in diabetic mice.
Topics: Alginates; Animals; Capsules; Diabetes Mellitus, Experimental; Dogs; Female; Glucuronic Acid; Graft Survival; Hexuronic Acids; Humans; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Mice; Mice, Inbred C57BL; Peptides; Transplantation, Heterologous | 1986 |
Xenograft transplantation of encapsulated canine pancreas into chemically induced diabetic rats.
Topics: Alginates; Animals; Biocompatible Materials; Capsules; Diabetes Mellitus, Experimental; Dogs; Glucuronic Acid; Hexuronic Acids; Male; Membranes, Artificial; Pancreas Transplantation; Peptides; Rats; Rats, Inbred Strains; Transplantation, Heterologous | 1985 |